Quality Investor

Community Health Systems, Inc.

Rank #14ValueWatchlistCompare with other stocks

CYH · NYSE · Healthcare

Community Health Systems, Inc. (CYH) — Rank #14 by gross profitability (GP/assets 0.87) · ROE -36.6% · Piotroski F-Score 8 / 9.

As-of 2026-10-30 · CIK 0001108109 · all metrics point-in-time as of the filing date.

About

Community Health Systems, Inc. owns, leases, and operates general acute care hospitals in the United States.

Show more

The company offers general acute care, emergency room, general and specialty surgery, critical care, internal medicine, obstetrics, diagnostic, psychiatric, and rehabilitation services, as well as skilled nursing and home care services. It also provides outpatient services at primary care practices, urgent care centers, free-standing emergency departments, ambulatory surgery centers, imaging and diagnostic centers, and direct-to-consumer virtual health visits. Community Health Systems, Inc.

was founded in 1985 and is headquartered in Franklin, Tennessee.

Industry
Medical Care Facilities
Sector
Healthcare
State
DE
Filer Category
Accelerated filer
Fiscal Year End
December 31
Website
chs.net

Company Snapshot

P/E and dividend yield are the primary valuation lenses for mature businesses.

Market Cap

—

P/E (annual)

—

P/S (annual)

—

P/B

—

P/OCF (annual)

—

Shareholder Yield

—

Employees

44,000

Industry

Medical Care Facilities

Exchange

NYSE

10/12

Flags passed

CYH fails 1 critical flag

Passes 10 of 12 quality flags, 1 caution

  • FAIL
    Revenue declining YoY

    Revenue contracted year over year

  • CAUTION
    Dilution above 2%

    Annual share count increase exceeds 2%. May be acceptable for high-growth companies funding talent via stock compensation

  • PASS
    Gross margin holding
  • PASS
    FCF not negative from investment
  • PASS
    Disclosure consistent
  • PASS
    Operating margin holding
  • PASS
    Free cash flow intact
  • PASS
    Passes safety gate
  • PASS
    Balance sheet stable
  • PASS
    No competitive retreat
  • PASS
    SBC not compressing margin
  • PASS
    No valuation convergence

Strengths Operating leverage expanding · Sequential beat (rev + EPS)

A count of the 12 warning flags that could be evaluated. Unweighted: colour follows the worst flag.

Quality Profile

Profitability

1/1 pass
GP / assets
0.87
Return on equity
-36.6%
Gross margin trend
PASS

Safety

1/1 pass
Balance-sheet safety
PASS
Debt / equity
—
Current ratio
1.53×
Net cash
-$9.40B

Cash Flow

2/3 pass
Positive FCF
PASS
Cash-backed earnings
WARN
Accruals healthy
PASS
SBC / revenue
0.1%

Growth

0/2 pass
Revenue growth
-1.2%
Piotroski F-Score
8 / 9
Share dilution
2.2%

Dividend yield and payout ratio are the primary reads at this stage (trailing P/E — see valuation above).

Profitability

Does it make money well?

Warning: Revenue declining YoY · GP/assets 0.87

Gross profitability (GP / assets)

0.87

Primary signal (Novy-Marx).

1st of 7 SIC 80 peers

Return on equity

-36.6%

Gross margin

85.1%

1st of 7 SIC 80 peers

Revenue growth (YoY)

-1.2%

Gross margin improving

Margin trend vs prior year.

PASS

Operating Leverage

2022202320242025
Revenue vs COGS
Revenue vs OpEx
Op. Income vs Revenue

Growth

Revenue CAGR (3Y)

0.7%

Revenue CAGR (5Y)

1.2%

Earnings CAGR (3Y)

122.8%

FCF CAGR (3Y)

—

Cash Flow Health

Is the cash real?

No warning flags · FCF 59% below net income

Free cash flow

$208.00M

Operating cash flow minus capex.

Positive free cash flow

PASS

FCF vs net income

-59.1%

(FCF − net income) ÷ |net income|. Positive: cash above earnings. Negative: below.

FCF not below net income

Fails when free cash flow is below net income (yellow flag).

WARN

Accruals healthy

Cash-backed earnings.

PASS

SBC / revenue

0.1%

Stock-based comp intensity.

Balance Sheet Strength

Can it survive a storm?

Caution: Dilution above 2% · net debt $9.40B, F-Score 8/9

Balance-sheet safety

Composite anti-fragile check.

PASS

Debt / equity

—

Current ratio

1.53×

6th of 7 SIC 80 peers

Quick ratio

1.14×

Net cash

-$9.40B

Cash & equivalents minus total debt.

Piotroski F-Score

8 / 9

Fundamental-strength score (0-9).

Valuation

Is the price reasonable?

No warning flags

Capital allocation quality

Composite score

3.3 / 5

Good
Share count trend
2.2%2/5 Fair
Buyback timing
N/AN/A
Dividend growth consistency(non-payer or broken streak)
0 yr3/5 Good
Net debt trajectory(deleveraging)
9.7%5/5 Strong

Lifecycle Phase History

20202025
Value
Startup

Price History

CYH-74.8% · -24.1% CAGRSPY+82.9% · +12.8% CAGR